Skip to main content
. 2017 Apr 1;33(9):1313–1322. doi: 10.1007/s10554-017-1124-0

Table 1.

Procedural details

Scaffold Absorb BVS (n = 6) Mirage BRMS (n = 11) p
Implanted vessel
 LAD/LCx/RCA (n) 1/3/2 4/2/5
Device
 Device nominal size (mm) 3.0 ± 0 3.18 ± 0.37 0.12
 Device length (mm) 17.5 ± 1.22 14.63 ± 0.81 <0.001
 Expected maximum device diameter (mm) 3.05 ± 0.12 3.43 ± 0.42 0.01
 Maximum deployment pressure (atm) 7.0 ± 0 9.82 ± 4.85 0.28
Pre-dilatation
 Pre dilatation performed, n (%) 0 (0%) 0 (0%) 1.00
Post-dilatation
 Post dilatation performed, n (%) 6 (100%) 11 (100%) 1.00
 Post dilatation balloon type
  Semi-compliant balloon, n (%) 0 (0%) 0 (0%)
  Non-compliant balloon, n (%) 6 (100%) 11 (100%) 1.00
 Balloon nominal size (mm) 3.5 ± 0.0 3.57 ± 0.53 0.34
 Maximum post-dilatation balloon pressure (atm) 8.5 ± 2.74 16.36 ± 2.34 0.001
 Maximum expected post-dilatation balloon size (mm) 3.37 ± 0.093 3.65 ± 0.59 0.08